What Clinical Evidence Means
Vinay Prasad opens with a blunt standard: a fall COVID booster without clinical evidence is a public health failure. That same standard pressures longevity biotech. Peter Attia applies it to diet and aging, saying the best approach is not definitively known. The contrast is useful: skeptics demand outcome trials, while entrepreneurs cite mechanisms and early human experiments, including BioViva's gene therapy work.






